Press Release: Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments PR Newswire NEW HAVEN, Conn., May 9, 2024 -- Cash, cash equivalents, marketable securities and restricted c
Director Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN)
Director Gregory Bailey Acquires 48,780 Shares of Biohaven Ltd (BHVN)
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Becton Dickinson (BDX)
Biohaven Announces $200M Public Offering Of Common Shares
Biohaven Ltd. (NYSE:BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscie
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Zoetis (ZTS) and Ginkgo Bioworks Holdings (DNA)
Buy Rating Affirmed for Biohaven Ltd. Amid Positive Clinical Outlook and Pipeline Potential
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
Buy Rating Affirmed: Biohaven Ltd. Poised for Key Milestones With Diverse Portfolio and Promising Lead Molecule BHV-7000
Buy Rating Affirmed for Biohaven Ltd. on Strong Pipeline and Upcoming Drug Advancements
Piper Sandler Remains a Buy on Biohaven Ltd. (BHVN)
Analysts Offer Insights on Healthcare Companies: Seer (SEER) and Biohaven Ltd. (BHVN)
Calculating The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Biohaven fair value estimate is US$46.01 Biohaven's US$49.50 share price indicates it is trading at similar levels as its fair value estimate
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
Biohaven Ltd. Poised for Growth: A Buy Rating Justified by Clinical Advances and Pipeline Expansion
Buy Rating for Biohaven Ltd. on Strong Drug Pipeline and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Precision BioSciences (DTIL) and Healthequity (HQY)
Director Irina Antonijevic Sells 11,000 Shares of Biohaven Ltd (BHVN)
Buy Rating for Biohaven Ltd. on Strong BHV-7000 Prospects in MDD and Epilepsy Markets
Buy Rating for Biohaven Ltd.: Promising Developments in BHV-1300 and BHV-7000 Programs and Potential Offset of Operating Expenses
No Data